image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Bovis Homes - House builder targets 50% increase in output; price target 1588p

March 2016

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • BVS
  • Price:
  • 840p
Amidst the intense volatility in share prices it would be understandable if investors missed the fact that the stars are once again aligning for UK house builders. The irony is that this volatility has actually pushed back market expectations for the first interest rate rise to come in 2019, while supply constraints and the Government’s Help-to-buy scheme are fanning expectations for another spike in house prices. This provides a wonderful platform for FTSE-250 listed Bovis Homes (also a TMI NAP for 2016), which has more than three quarters of its land bank in the prosperous South and is focused on family houses, either edge of town or within large villages.Finance director, Earl Sibley, who we spoke with over the month, note ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X